Oral ginseng formulae for stable chronic obstructive pulmonary disease: A systematic review

Respiratory Medicine

Volumn 105, Issue 2, 2011, Pages 165-176

  An, Xuedong ^a   Zhang, Anthony Lin ^a   Yang, Angela Weihong ^a   Lin, Lin ^b   Wu, Darong ^b   Guo, Xinfeng ^b,e   Shergis, Johannah Linda ^a   Thien, Francis Chung Kong ^c   Worsnop, Christopher J ^d   Xue, Charlie Changli ^a  

^a RMIT UNIVERSITY   (Australia)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^c BOX HILL HOSPITAL   (Australia)

^d AUSTIN HOSPITAL   (Australia)

^e GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Chinese herbal medicine; Chronic obstructive pulmonary disease; COPD; Ginseng formulae; Systematic review

Indexed keywords

GINSENG EXTRACT; PLACEBO;

APPETITE; BLOATING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FORCED EXPIRATORY VOLUME; GINSENG; HEALTH SURVEY; HUMAN; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SPIROMETRY; SYSTEMATIC REVIEW; XEROSTOMIA;

ADMINISTRATION, ORAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PANAX; PHYTOTHERAPY; PLANT PREPARATIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78651397481     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.11.007     Document Type: Review

References (43)

1. K.R. Chapman, D.M. Mannino, and J.B. Soriano Epidemiology and costs of chronic obstructive pulmonary disease Eur Respir J 27 2006 188 207
2. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study Lancet 349 1997 1498 1504
3. A.S. Buist, M.A. McBurnie, and W.M. Vollmer International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study Lancet 370 2007 741 750
4. N. Zhong, C. Wang, and W. Yao Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey Am J Respir Crit Care Med 176 2007 753 760
5. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for diagnosis management and prevention of COPD 2008 http://www.goldcopd.org
6. M. Abramson, A.J. Crockett, and P.A. Frith The COPD-X Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2009 2009 http://www.copdx.org.au/guidelines
7. S.H. Saydah, and M.S. Eberhardt Use of complementary and alternative medicine among adults with chronic diseases J Altern Complement Med 2006 12 2002 805 812 United States
8. D.H. Mehta, P.M. Gardiner, and R.S. Phillips Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions J Altern Complement Med 14 2008 1263 1269
9. A.L. Zhang, D.F. Story, and V. Lin A population survey on the use of 24 common medicinal herbs in Australia Pharmacoepidemiol Drug Saf 17 2008 1006 1013
10. World Health Organization (WHO) International standard Terminologies on traditional medicine in the Western Pacific Region 2007 WHO
11. J.A. Shen Za bing Yuan Liu Xi Zhu 2006 People's Medical Publishing House Beijing
12. X.C. Ding, and Z. Wang Review of chronic obstructive pulmonary disease in stable stage treated with TCM J Zhejiang Univ Tradit Chin Med 32 2008 131 132
13. R. Guo, M.H. Pittler, and E. Ernst Herbal medicines for the treatment of COPD: a systematic review Eur Respir J 28 2006 330 338
14. Cochrane review groups Search methods guide: 2008 http://www.airways. cochrane.org
15. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions (version 5.0.1) 2008 http://www.cochrane-handbook.org
16. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
17. Q.H. Chen Clinical observation of the therapeutic effect of yifei pill in treatment of chronic obstructive pulmonary disease Fujian J Tradit Chin Med 35 2004 13 14
18. Y.F. Chen, and X.Y. Hu Clinical study on effect of feikangning capsule on patients with chronic obstructive pulmonary disease in stable phase J Mod Clin Med 33 2007 332 334
19. W.X. Guo, F. Yu, and C.Y. Zhang Clinical observation of the therapeutic efffect jian fei capsule on chronic obstructive pulmonary disease stationary phase Hebei J Traditional Chin Med 30 2008 121 123
20. M.L. Hong, G.Z. Yang, and W.X. Chen Effect of yufeining on induced sputum interleukin-8 in patients with chronic obstructive pulmonary disease at the stable phase Chin J Integr Med 11 2005 179 182
21. D.H. Huang, L. Wu, and D.P. He Clinical observation of stable chronic obstructive pulmonary disease treated by integration of traditional Chinese medicine and Western medicine J Fourth Milit Med Univ 26 2005 1611 1613
22. D.W. Huang, P. Chen, and Y.Z. Li The influence of herb to reinforce lung and consolidate origin on the ventilative function of lung in the patients of chronic obstructive pulmonary disease Chin J Inf Traditional Chin Med 9 2002 17 18
23. S.Y. Li, Q.W. Zhou, and M.H. Wang Effect of bufei yishen granule on pulmonary ventilation function and immunological function of patients with chronic obstructive pulmonary disease in remission phase: a randomized grouping and placebo controlled study Chin J Clin Rehabil 10 2006 145 147
24. L. Lin, C.Y. Tang, and Y.J. Xu Clinical observation of spleen-lung nourishing granule in treating respiratory muscle fatigue of stable chronic obstructive pulmonary disease Shanghai J Traditional Chin Med 37 2003 10 12
25. B. Wu Clinical observation of jiawei shenge granule on effect of lung function for chronic obstructive pulmonary disease at remission stage Med Industry Information 3 2006 70
26. G. Xiong, S. Chen, and W. Xie Clinical observation of shenge granule on effect of lung function and serum IL-8, TNF-α for stable chronic obstructive pulmonary disease Chin J Geriatr Care 6 2008 37 39
27. X.Y. Xu, Q.R. Liu, and J. Chen Clinical observation of Qi deficiency syndrome in 72 patients with chronic obstructive pulmonary disease treated with yiqi mianyi granule Zhongguo Zhong Xi Yi Jie He Za Zhi 16 1996 81 83
28. D. Gross, Z. Shenkman, and B. Bleiberg Ginseng improves pulmonary functions and exercise capacity in patients with COPD Monaldi Arch Chest Dis 57 2002 242 246
29. Chinese Medical Association of Respiratory Diseases (chronic obstructive pulmonary disease study group) Chronic obstructive pulmonary disease diagnosis and treatment guidelines Chin J Tuberculosis Respir 25 2002 453 460
30. ATS Standardization of spirometry-1987 update. Statement of the American Thoracic Society Am Rev Respir Dis 136 1987 1285 1298
31. M.R. Miller, J. Hankinson, and V. Brusasco Standardisation of spirometry Eur Respir J 26 2005 319 338
32. X.Y. Zheng Chinese medicine clinical research of new drugs on the guiding principles (for trial implementation) 2002 China Medical Science and Technology Publishing House Beijing, China
33. G.D. Qi, D.A. We, and L.P. Chung Placebos used in clinical trials for Chinese herbal medicine Recent Pat Inflamm Allergy Drug Discov 2 2008 123 127
34. P. Juni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46
35. L.M. Fabbri, P.M. Calverley, and J.L. Izquierdo-Alonso Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials Lancet 374 2009 695 703
36. D.P. Tashkin, B. Celli, and S. Senn A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
37. A.B. Tonnel, T. Perez, and J.M. Grosbois Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD Int J Chron Obstruct Pulmon Dis 3 2008 301 310
38. S.M. Swanson, J.X. Jiang, and Y.S. Chang A rapid and sensitive bioassay involving cultured rat glioma cells to screen for substances capable of elevating intracellular cyclic AMP concentration J Nat Prod 51 1988 929 936
39. M.T. Park, H.J. Cha, and J.W. Jeong Glucocorticoid receptor-induced down-regulation of MMP-9 by ginseng components, PD and PT contributes to inhibition of the invasive capacity of HT1080 human fibrosarcoma cells Mol Cells 9 1999 476 483
40. S.H. Jung, M.S. Woo, and S.Y. Kim Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells Int J Cancer 118 2006 490 497
41. B.M. Lee, S.K. Lee, and H.S. Kim Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, beta-carotene and red ginseng) Cancer Lett 132 1998 219 227
42. J.Y. Cho, E.S. Yoo, and K.U. Baik In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-alpha production and its modulation by known TNF-alpha antagonists Planta Med 67 2001 213 218
43. J.T. Coon, and E. Ernst Panax ginseng: a systematic review of adverse effects and drug interactions Drug Saf 25 2002 323 344